Mingchen Zhu

633 citations
26 papers · 496 indexed · h-index 11
Topics
MicroRNA in disease regulation (5 papers)RNA modifications and cancer (4 papers)Immunotherapy and Immune Responses (4 papers)
Partner nations
ChinaUnited States

In The Last Decade

Mingchen Zhu

25 papers receiving 491 citations

Peers

Mingchen Zhu
Comparison fields: 5 of 81
  • Molecular Biology 374
  • Cancer Research 262
  • Oncology 76
  • Immunology 58
  • Physiology 32
Replace Timothy Wai Ho Shuen with:
Timothy Wai Ho Shuen Singapore
Qiqi Shi China
Alicia M. Blessing United States
Shuliang Shi China
Komal Qureshi-Baig Luxembourg
Christopher M. Dower United States
Rujun Mo China
Paola Tiberio Italy
Mingchen Zhu relative to Timothy Wai Ho Shuen Singapore Timothy Wai Ho Shuen's profile →
Citations per field
00.5×3.7×
Timothy Wai Ho Shuen · 1×
Citations per year

Countries citing papers authored by Mingchen Zhu

Since Specialization
Citations

This map shows the geographic impact of Mingchen Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingchen Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingchen Zhu more than expected).

Fields of papers citing papers by Mingchen Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingchen Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingchen Zhu. The network helps show where Mingchen Zhu may publish in the future.

Co-authorship network of co-authors of Mingchen Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Mingchen Zhu. A scholar is included among the top collaborators of Mingchen Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingchen Zhu. Mingchen Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 3
5 6
6 4
7 11
8 68
9 45
10 2
11 143
12 12
13 10
14 9
15 29
16 5
17 23
18 5
19
Expressions of HLA-A and B mRNA in peripheral blood mononuclear cells in patients with esophagus cancer of the neck.
1
20 21

About Mingchen Zhu

Mingchen Zhu is a scholar working on Cancer Research, Biological Psychiatry and Transplantation, having authored 26 papers that have together received 496 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), RNA modifications and cancer (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Cancer Research (262 citations), Physiology (32 citations) and Molecular Biology (374 citations). Mingchen Zhu has collaborated with scholars based in China and United States. Frequent co-authors include Yijun Xu, Feng Yan, Yun Chen, Lijie Xing, Xin Wang, Lili Feng, Yiqing Cai, Mengyuan Ge, Xun Lu and Hao Liu. Their work appears in journals such as Pattern Recognition, Mechanical Systems and Signal Processing and Clinica Chimica Acta.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026